Home NEWS Vetiva Capital MD Mudashiru Killed In Hit-And-Run Accident

Vetiva Capital MD Mudashiru Killed In Hit-And-Run Accident

by InlandTown Editor
0 comment

Laolu Mudashiru, co-founder and deputy managing director of a prominent capital management company in Nigeria, Vetiva Capital, has died.

The businessman cum investment banker was reportedly riding a bicycle with a group of cyclists when a car plowed into their bikes on Gerrard Road in the affluent neighborhood of Ikoyi, Lagos, and sped off, leaving them with very serious injuries.

Reports have it that the investment banker, after he was hit by the yet-to-be apprehended driver was taken to a nearby hospital with the other victims, where he was pronounced dead.

His demise came as a shock to stakeholders in the Nigerian capital market as he was one of the best brains in the ecosystem.

Mudashiru, fondly called Dr Bob, was trained as a medical doctor. He was born in 1968 to the family of late Air Commodore Gbolahan Mudashiru, a former Lagos State Military Administrator.

The investment banker had extensive experience in stock broking, asset management and other aspects of investment banking activities. He obtained an MSc in International Securities, Investments and Banking from the ICMA Centre of the University of Reading, the UK, and an MBBS degree from the College of Medicine, University of Lagos.

He was a dealing member of the London Stock Exchange, an Associate of the Chartered Institute of Stockbrokers, Nigeria, as well as a member of the Medical and Dental Council of Nigeria.

Until his death, he was the Deputy Managing Director of Vetiva Capital, which has Vetiva Securities Limited, Vetiva Fund Managers Limited and Vetiva Trustees Limited as its wholly-owned subsidiaries.

Related Articles

Leave a Comment

* By using this form you agree with the storage and handling of your data by this website.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More